Plunkett Research Online: Lonza Group Ltd

LONZA GROUP LTD (LZAGF:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Lonza Group Ltd. comprises a global portfolio of companies engaged in the production and supply of active pharmaceutical ingredients, both biotechnological and chemical, for a range of clients in the healthcare, pharmaceutical and life science industries. The group structure was established in 1999.....



Lonza Group Ltd
Ticker: LZAGF
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 41 613168111
Fax: 41 613169111
Address: Muenchensteinerstrasse 38
Basel, 4002 Switzerland

Types Of Business
Industry Ranks

Industry NAICS code:

Chemicals Manufacturing
Fine Chemicals & Pharmaceutical Intermediates
Biocides
Materials Research
Active Drug Ingredients
Monoclonal Antibody Drugs
ContactsDescription

Richard RidingerCEO
Rodolfo SavitzkyCFO
See More
Lonza Group Ltd. comprises a global portfolio of companies engaged in the production and supply of active pharmaceutical ingredients, both biotechnological and chemical, for a range of clients in the healthcare, pharmaceutical and life science industries. The group structure was established in 1999.....See More See More

Auditor: KPMG AG
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Lonza AG
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: